Biomarkers identified for idiopathic pulmonary fibrosis

The first evidence of a distinctive protein signature that could help to transform the diagnosis and improve the monitoring of the devastating lung disease idiopathic pulmonary fibrosis (IPF) is being reported by University of Pittsburgh School of Medicine researchers in this month’s edition of PLoS Medicine, an open-access journal of the Public Library of Science.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news128668851.html">Biomarkers identified for idiopathic pulmonary fibrosis</a></p> <p>The first evidence of a distinctive protein signature that could help to transform the diagnosis and improve the monitoring of the devastating lung disease idiopathic pulmonary fibrosis (IPF) is being reported by University of Pittsburgh School of Medicine researchers in this month’s edition of <i>PLoS Medicine</i>, an open-access journal of the Public Library of Science.</p>